Implantable electrophysiologic cardiac device infections: A risk factor analysis

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 11, 2012, Pages 3015-3021

  Raad, D ^a   Irani, J ^b   Akl, E G ^c   Choueiri, S ^b   Azar, E ^b   Abboud, J ^b   Afif, C ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF BALAMAND   (Lebanon)

^c ENGLEWOOD HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; BIVARIATE ANALYSIS; CLINICAL ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; FEMALE; FOLLOW UP; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; MALE; MORGANELLA MORGANII; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSTHESIS INFECTION; PROTEUS MIRABILIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

AGED; AGED, 80 AND OVER; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; PACEMAKER, ARTIFICIAL; PREVALENCE; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84867990051     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-012-1655-1     Document Type: Article

References (30)

1. Bloom H et al (2006) Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery. Pacing Clin Electrophysiol 29(2):142-145
2. Epstein AE et al (2008) ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 51(21):e1-e62
3. Chua JD et al (2000) Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med 133(8):604-608
4. Sohail MR et al (2011) Mortality and cost associated with cardiovascular implantable electronic device infections. Arch Intern Med 171(20):1821-1828
5. Uslan DZ et al (2007) Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med 167(7):669-675
6. Lai KK, Fontecchio SA (1998) Infections associated with implantable cardioverter defibrillators placed transvenously and via thoracotomies: epidemiology, infection control, and management. Clin Infect Dis 27(2):265-269
7. Voigt A, Shalaby A, Saba S (2010) Continued rise in rates of cardiovascular implantable electronic device infections in the United States: temporal trends and causative insights. Pacing Clin Electrophysiol 33(4):414-419
8. Sohail MR et al (2007) Risk factor analysis of permanent pacemaker infection. Clin Infect Dis 45(2):166-173
9. Johansen JB et al (2011) Infection after pacemaker implantation: infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients. Eur Heart J 32(8):991-998
10. Baddour LM et al (2003) Nonvalvular cardiovascular device-related infections. Circulation 108(16):2015-2031
11. Durack DT, Lukes AS, Bright DK (1994) New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 96(3):200-209
12. Wiegand UK et al (2004) Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy. Chest 126(4):1177-1186
13. Klug D et al (2007) Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation 116(12):1349-1355
14. Takahashi T et al (2002) High incidence of device-related and lead-related complications in the dual-chamber implantable cardioverter defibrillator compared with the single-chamber version. Circ J 66(8):746-750
15. Kutinsky IB et al (2010) Risk of hematoma complications after device implant in the clopidogrel era. Circ Arrhythm Electrophysiol 3(4):312-318
16. Costea A et al (2008) Complications associated with generator replacement in response to device advisories. J Cardiovasc Electrophysiol 19(3):266-269
17. Gould PA, Krahn AD (2006) Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories. JAMA 295(16):1907
18. Kapa S et al (2007) Complication risk with pulse generator change: implications when reacting to a device advisory or recall. Pacing Clin Electrophysiol 30(6):730-733
19. Curtis AB, Ellenbogen KA, Hammill SC, Hayes DL, Reynolds DW, Wilber DJ, Cain ME (2004) Heart Rhythm Society Clinical competency statement: training pathways for implantation of cardioverter defibrillators and cardiac resynchronization devices. Heart Rhythm 1(3):371-375
20. Chauhan A et al (1994) Early complications after dual chamber versus single chamber pacemaker implantation. Pacing Clin Electrophysiol 17(11):2012-2015
21. Nery PB et al (2010) Device-related infection among patients with pacemakers and implantable defibrillators: incidence, risk factors, and consequences. J Cardiovasc Electrophysiol 21(7):786-790
22. Margey R et al (2010) Contemporary management of and outcomes from cardiac device related infections. Europace 12(1):64
23. Howarth DM, Curteis PG, Gibson S (1998) Infected cardiac pacemaker wires demonstrated by Tc-99 m labeled white blood cell scintigraphy. Clin Nucl Med 23(2):74
24. Dasgupta A et al (2007) Increased complication rates of cardiac rhythm management devices in ESRD patients. Am J Kidney Dis 49(5):656-663
25. Greenspon AJ et al (2011) 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States: 1993 to 2008. J Am Coll Cardiol 58(10):1001-1006
26. Le KY et al (2011) Clinical predictors of cardiovascular implantable electronic device-related infective endocarditis. Pacing Clin Electrophysiol 34(4):450-459
27. Parsonnet V, Bernstein AD, Lindsay B (1989) Pacemaker-implantation complication rates: an analysis of some contributing factors. J Am Coll Cardiol 13(4):917-921
28. Al-Khatib SM et al (2005) The relation between patients' outcomes and the volume of cardioverter-defibrillator implantation procedures performed by physicians treating Medicare beneficiaries. J Am Coll Cardiol 46(8):1536-1540
29. Remmelts HH et al (2009) Infection after ICD implantation: operating room versus cardiac catheterisation laboratory. Neth Heart J 17(3):95-100
30. Glieca F et al (1987) The role of antibiotic prophylaxis in the implantation of pacemakers. Minerva Cardioangiol 35(10):549-552